Sionna Therapeutics, Inc. Common Stock SION Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -26.7%— | —— | —— | —— | —— | |
| Return on invested capital | -38.8%— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 22.6×+2.0× | 20.6×-5.0× | 25.6×-9.7× | 35.3×+6.6× | 28.7×+14.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | |
| Per Share | ||||||
| Book value per share | $6.42-16.4% | $7.68+5.6% | $7.27-99.9% | $7,625.84+57,556% | $13.23+131% | |
| Valuation | ||||||
| Market capitalization | $1.8B-1.7% | $1.84B+41.4% | $1.3B+83.6% | $707.24M— | —— | |
| Price / book | 6.3×+0.3× | 6×+1.9× | 4×+1.9× | 2.1×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Sionna Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Sionna Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.